ZW9087A1 - Dopamine-b-hydroxylase inhibitors - Google Patents

Dopamine-b-hydroxylase inhibitors

Info

Publication number
ZW9087A1
ZW9087A1 ZW90/87A ZW9087A ZW9087A1 ZW 9087 A1 ZW9087 A1 ZW 9087A1 ZW 90/87 A ZW90/87 A ZW 90/87A ZW 9087 A ZW9087 A ZW 9087A ZW 9087 A1 ZW9087 A1 ZW 9087A1
Authority
ZW
Zimbabwe
Prior art keywords
dopamine
hydroxylase inhibitors
hydroxylase
inhibitors
Prior art date
Application number
ZW90/87A
Other languages
English (en)
Inventor
Alan Finkelstein Joseph
Ivan Kruse Lawrence
Original Assignee
Smithkline Beckman Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beckman Corp filed Critical Smithkline Beckman Corp
Publication of ZW9087A1 publication Critical patent/ZW9087A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C07D249/10—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D249/12—Oxygen or sulfur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
ZW90/87A 1986-05-23 1987-05-18 Dopamine-b-hydroxylase inhibitors ZW9087A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US86643786A 1986-05-23 1986-05-23

Publications (1)

Publication Number Publication Date
ZW9087A1 true ZW9087A1 (en) 1987-09-02

Family

ID=25347617

Family Applications (1)

Application Number Title Priority Date Filing Date
ZW90/87A ZW9087A1 (en) 1986-05-23 1987-05-18 Dopamine-b-hydroxylase inhibitors

Country Status (15)

Country Link
EP (1) EP0246888A3 (xx)
JP (1) JPS62283967A (xx)
KR (1) KR870011109A (xx)
CN (1) CN87103808A (xx)
AU (1) AU7334487A (xx)
DK (1) DK251087A (xx)
FI (1) FI872249A (xx)
HU (1) HU201530B (xx)
IL (1) IL82542A0 (xx)
NO (1) NO872094L (xx)
NZ (1) NZ220347A (xx)
PH (1) PH23506A (xx)
PT (1) PT84904B (xx)
ZA (1) ZA873653B (xx)
ZW (1) ZW9087A1 (xx)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4628059A (en) * 1985-10-31 1986-12-09 Smithklein Beckman Corporation Dopamine-β-hydroxylase inhibitors
DE4230466A1 (de) * 1992-09-11 1994-03-17 Basf Ag Verfahren zur katalytischen Herstellung von Kondensationsprodukten des Formaldehyds
KR101955691B1 (ko) 2010-03-30 2019-03-07 베르선 코포레이션 트롬빈 억제제로서의 다중치환된 방향족 화합물
CN105209440B (zh) 2013-03-15 2019-07-23 维颂公司 作为凝血酶抑制剂的卤代吡唑
RU2019101889A (ru) 2013-03-15 2019-03-28 Версеон Корпорейшн Полизамещенные ароматические соединения в качестве ингибиторов сериновых протеаз
CA2960790A1 (en) 2014-09-17 2016-03-24 Verseon Corporation Pyrazolyl-substituted pyridone compounds as serine protease inhibitors
US10532995B2 (en) 2015-02-27 2020-01-14 Verseon Corporation Substituted pyrazole compounds as serine protease inhibitors

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5634673A (en) * 1979-08-31 1981-04-06 Nippon Nohyaku Co Ltd 1,2,4-triazoles and agricultural and horticultural fungicide containing the same
JPS59164783A (ja) * 1983-03-11 1984-09-17 Nippon Soda Co Ltd トリアゾ−ルジスルフイド誘導体及びその製造方法
PT78388B (en) * 1983-04-12 1986-09-15 Smithkline Beckman Corp Dopamine-beta-hydroxylase inhibitors
US4628059A (en) * 1985-10-31 1986-12-09 Smithklein Beckman Corporation Dopamine-β-hydroxylase inhibitors

Also Published As

Publication number Publication date
DK251087A (da) 1987-11-24
KR870011109A (ko) 1987-12-21
FI872249A (fi) 1987-11-24
JPS62283967A (ja) 1987-12-09
NO872094L (no) 1987-11-24
EP0246888A3 (en) 1988-09-28
PH23506A (en) 1989-08-16
ZA873653B (en) 1988-08-31
FI872249A0 (fi) 1987-05-21
HUT47920A (en) 1989-04-28
PT84904B (en) 1989-07-17
HU201530B (en) 1990-11-28
PT84904A (en) 1987-06-01
NO872094D0 (no) 1987-05-19
DK251087D0 (da) 1987-05-18
IL82542A0 (en) 1987-11-30
NZ220347A (en) 1990-05-28
AU7334487A (en) 1987-11-26
EP0246888A2 (en) 1987-11-25
CN87103808A (zh) 1987-12-09

Similar Documents

Publication Publication Date Title
GR862032B (en) Dopamine-b-hydroxylase inhibitors
GR871770B (en) Renin inhibitors
ZW21586A1 (en) Dopamine-b-hydroxylase inhibitors
ZW9087A1 (en) Dopamine-b-hydroxylase inhibitors
PT85596B (en) Dopamine-beta-hydroxylase inhibitors
GB8706045D0 (en) Block polyurethane-amides
EP0266779A3 (en) Scale inhibitor
CS966786A1 (en) Vlhcici zarizeni
GR860362B (en) Dopamine -b-hydroxylase inhibitors
IE862056L (en) DOPAMINE-ß-HYDROXYLASE INHIBITORS
IE860327L (en) DOPAMINE-ß-HYDROXYLASE INHIBITORS
CS494486A1 (en) Inhibitor koroze hlinikovych slitin
IE872276L (en) DOPAMINE-ß-HYDROXYLASE INHIBITORS
GB8600896D0 (en) Scale inhibitors
KR890009193Y1 (en) Block
IE860036L (en) DOPAMINE - ß - HYDROXYLASE INHIBITORS.
CS862387A1 (en) Smesny inhibitor koroze oceli
CS25787A1 (en) Inhibitor koroze
IE861951L (en) Enzyme inhibitors
IE862387L (en) Irreversible dopamine-b-hydroxylase inhibitors
BG50511A1 (en) Nest- shaper for plant- machine
CS74285A1 (en) Smesny vyparovaci inhibitor koroze kovu
IE852172L (en) L - glucosidase inhibitor
IE852330L (en) Ó-d-mannosidase inhibitor
IE862859L (en) INHIBITORS OF DOPAMINE-ß-HYDROXYLASE